Related references
Note: Only part of the references are listed.Triclosan Resistance of Pseudomonas aeruginosa PAO1 Is Due to FabV, a Triclosan-Resistant Enoyl-Acyl Carrier Protein Reductase
Lei Zhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Mechanism and Inhibition of the FabV Enoyl-ACP Reductase from Burkholderia mallei
Hao Lu et al.
BIOCHEMISTRY (2010)
Drug-target residence time: critical information for lead optimization
Hao Lu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
A Slow, Tight Binding Inhibitor of InhA, the Enoyl-Acyl Carrier Protein Reductase from Mycobacterium tuberculosis
Sylvia R. Luckner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Essentiality of FASII pathway for Staphylococcus aureus
Wendy Balemans et al.
NATURE (2010)
Slow-Onset Inhibition of the Fabl Enoyl Reductase from Francisella tularensis: Residence Time and in Vivo Activity
Hao Lu et al.
ACS CHEMICAL BIOLOGY (2009)
Jalview Version 2-a multiple sequence alignment editor and analysis workbench
Andrew M. Waterhouse et al.
BIOINFORMATICS (2009)
Substituted diphenyl ethers as a broad-spectrum platform for the development of chemotherapeutics for the treatment of tularaemia
Kathleen England et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
Sophie Brinster et al.
NATURE (2009)
Inhibitors of Fabl, an enzyme drug target in the bacterial fatty acid biosynthesis pathway
Hao Lu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Residence time of receptor-ligand complexes and its effect on biological function
Peter J. Tummino et al.
BIOCHEMISTRY (2008)
Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus
Hua Xu et al.
BIOCHEMISTRY (2008)
Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coli
Salma Rafi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Isothermal amplification and molecular typing of the obligate intracellular pathogen Mycobacterium leprae isolated from tissues of unknown origins
NA Groathouse et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis
Todd J. Sullivan et al.
ACS CHEMICAL BIOLOGY (2006)
Triclosan inhibition of fatty acid synthesis and its effect on growth of Escherichia coli and Pseudomonas aeruginosa
MG Escalada et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Melioidosis: Epidemiology, pathophysiology, and management
AC Cheng et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
BpeAB-OpRB, a multidrug efflux pump in Burkholderia pseudomallei
YY Chan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Inhibition of the bacterial enoyl reductase FabI by triclosan: A structure-reactivity analysis of FabI inhibition by triclosan analogues
S Sivaraman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei
MTG Holden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Biochemical mechanisms of drug action: what does it take for success?
DC Swinney
NATURE REVIEWS DRUG DISCOVERY (2004)
The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase:: Adduct affinity and drug resistance
R Rawat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan:: Kinetic analysis of mutant
S Sivaraman et al.
BIOCHEMISTRY (2003)
Microbiology - A triclosan-resistant bacterial enzyme
RJ Heath et al.
NATURE (2000)
Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid
SL Parikh et al.
BIOCHEMISTRY (2000)
Recent advances in the treatment of severe melioidosis
W Chaowagul
ACTA TROPICA (2000)
Share Paper
